These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 12862433

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. PDEPT: polymer-directed enzyme prodrug therapy. I. HPMA copolymer-cathepsin B and PK1 as a model combination.
    Satchi R, Connors TA, Duncan R.
    Br J Cancer; 2001 Sep 28; 85(7):1070-6. PubMed ID: 11592781
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo activities of a doxorubicin prodrug in combination with monoclonal antibody beta-lactamase conjugates.
    Svensson HP, Vrudhula VM, Emswiler JE, MacMaster JF, Cosand WL, Senter PD, Wallace PM.
    Cancer Res; 1995 Jun 01; 55(11):2357-65. PubMed ID: 7757987
    [Abstract] [Full Text] [Related]

  • 6. The structure-dependent toxicity, pharmacokinetics and anti-tumour activity of HPMA copolymer conjugates in the treatment of solid tumours and leukaemia.
    Tomalova B, Sirova M, Rossmann P, Pola R, Strohalm J, Chytil P, Cerny V, Tomala J, Kabesova M, Rihova B, Ulbrich K, Etrych T, Kovar M.
    J Control Release; 2016 Feb 10; 223():1-10. PubMed ID: 26708020
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel.
    Šírová M, Strohalm J, Chytil P, Lidický O, Tomala J, Říhová B, Etrych T.
    J Control Release; 2017 Jan 28; 246():1-11. PubMed ID: 27940304
    [Abstract] [Full Text] [Related]

  • 9. Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation: effect of polymer chain modification.
    Chytil P, Etrych T, Konák C, Sírová M, Mrkvan T, Ríhová B, Ulbrich K.
    J Control Release; 2006 Sep 28; 115(1):26-36. PubMed ID: 16899320
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Polymeric drug-carriers containing doxorubicin and melanocyte-stimulating hormone: in vitro and in vivo evaluation against murine melanoma.
    O'Hare KB, Duncan R, Strohalm J, Ulbrich K, Kopeckova P.
    J Drug Target; 1993 Sep 28; 1(3):217-29. PubMed ID: 8069563
    [Abstract] [Full Text] [Related]

  • 12. Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic.
    Duncan R, Gac-Breton S, Keane R, Musila R, Sat YN, Satchi R, Searle F.
    J Control Release; 2001 Jul 06; 74(1-3):135-46. PubMed ID: 11489490
    [Abstract] [Full Text] [Related]

  • 13. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
    Nakamura H, Koziolová E, Chytil P, Tsukigawa K, Fang J, Haratake M, Ulbrich K, Etrych T, Maeda H.
    Mol Pharm; 2016 Dec 05; 13(12):4106-4115. PubMed ID: 27934482
    [Abstract] [Full Text] [Related]

  • 14. Comparison between linear and star-like HPMA conjugated pirarubicin (THP) in pharmacokinetics and antitumor activity in tumor bearing mice.
    Nakamura H, Koziolová E, Etrych T, Chytil P, Fang J, Ulbrich K, Maeda H.
    Eur J Pharm Biopharm; 2015 Feb 05; 90():90-6. PubMed ID: 25460144
    [Abstract] [Full Text] [Related]

  • 15. N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation.
    Searle F, Gac-Breton S, Keane R, Dimitrijevic S, Brocchini S, Sausville EA, Duncan R.
    Bioconjug Chem; 2001 Feb 05; 12(5):711-8. PubMed ID: 11562189
    [Abstract] [Full Text] [Related]

  • 16. Polyacetal-doxorubicin conjugates designed for pH-dependent degradation.
    Tomlinson R, Heller J, Brocchini S, Duncan R.
    Bioconjug Chem; 2003 Feb 05; 14(6):1096-106. PubMed ID: 14624622
    [Abstract] [Full Text] [Related]

  • 17. Gamma scintigraphy of the biodistribution of 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in mice with transplanted melanoma and mammary carcinoma.
    Pimm MV, Perkins AC, Strohalm J, Ulbrich K, Duncan R.
    J Drug Target; 1996 Feb 05; 3(5):375-83. PubMed ID: 8866656
    [Abstract] [Full Text] [Related]

  • 18. Synergistic enhancement of anticancer therapeutic efficacy of HPMA copolymer doxorubicin conjugates via combination of ligand modification and stimuli-response srategies.
    Li L, Zhou M, Huang Y.
    Int J Pharm; 2018 Jan 30; 536(1):450-458. PubMed ID: 29237570
    [Abstract] [Full Text] [Related]

  • 19. Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy.
    Etrych T, Kovář L, Strohalm J, Chytil P, Ríhová B, Ulbrich K.
    J Control Release; 2011 Sep 25; 154(3):241-8. PubMed ID: 21699933
    [Abstract] [Full Text] [Related]

  • 20. Antitumor activity of N-(2-hydroxypropyl) methacrylamide copolymer-Mesochlorine e6 and adriamycin conjugates in combination treatments.
    Shiah JG, Sun Y, Peterson CM, Straight RC, Kopecek J.
    Clin Cancer Res; 2000 Mar 25; 6(3):1008-15. PubMed ID: 10741728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.